We also observed that p21 directly interacts with CDK2 or PCNA, and the interaction between p21/CDK2 or p21/PCNA following parkin siRNA treatment was increased in A549 lung cancer cell lines (Fig 4E). The gene discussed is CDKN1A; the disease is lung carcinoma.